Article
Sequence variations in the osteoprotegerin gene promoter in patients with postmenopausal osteoporosis.
The Journal of clinical endocrinology and metabolism - 1 Sept 2002
Arko B, Prezelj J, Komel R, Kocijancic A, Hudler P, Marc J
Abstract excerpt
Osteoprotegerin (OPG) is a recently discovered member of the TNF receptor superfamily that acts as an important paracrine regulator of bone remodeling. OPG knockout mice develop severe osteoporosis, whereas administration of OPG can prevent ovariectomy-induced bone loss. These findings implicate a role for OPG in the development of osteoporosis. In the present study, we screened the OPG gene promoter for sequence...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
